Human Molecular Genetics Advance Access originally published online on April 20, 2005
Human Molecular Genetics 2005 14(11):1539-1547; doi:10.1093/hmg/ddi162
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy
1Department of Pathology, 2Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA, 3Department of Pediatrics and 4Department of Pathology, Texas Children's Hospital, 6621 Fannin, Houston, TX 77030, USA
* To whom correspondence should be addressed. Tel: +1 7137983141; Fax: +1 7137985838; Email: tcooper{at}bcm.tmc.edu
Received February 23, 2005; Accepted April 12, 2005
Myotonic dystrophy type I (DM1) is an RNA-mediated disease caused by a non-coding CTG repeat expansion. A key feature of the RNA-mediated pathogenesis model for DM is the disrupted splicing of specific pre-mRNA targets. A link has been established between splicing regulation by CUG-BP1, a member of the CELF family of proteins, and DM1 pathogenesis. To determine whether increased CUG-BP1 function was sufficient to model DM, transgenic mice overexpressing CUG-BP1 (MCKCUG-BP1) in heart and skeletal muscle, two tissues affected in DM1, were generated. Histological and electron microscopic analyses of skeletal muscle reveal common pathological features with DM tissues: chains of central nuclei, degenerating fibers and centralized NADH reactivity. MCKCUG-BP1 mice have disrupted splicing of three CELF target pre-mRNAs, cardiac troponin T (Tnnt2), myotubularin-related 1 gene (Mtmr1) and the muscle-specific chloride channel (Clcn1), consistent with that observed in DM heart and skeletal muscle. The results are consistent with a mechanism for DM pathogenesis in which expanded repeats result in increased CUG-BP1 activity and/or other CELF family members and have trans-dominant effects on specific pre-mRNA targets.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Zhang, J. E. Lee, J. Wilusz, and C. J. Wilusz The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells: IMPLICATIONS FOR MYOTONIC DYSTROPHY J. Biol. Chem., August 15, 2008; 283(33): 22457 - 22463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Subramaniam, G. Natarajan, S. Ramalingam, I. Ramachandran, R. May, L. Queimado, C. W. Houchen, and S. Anant Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2 Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G1025 - G1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mori, N. Sasagawa, Y. Kino, and S. Ishiura Quantitative Analysis of CUG-BP1 Binding to RNA Repeats J. Biochem., March 1, 2008; 143(3): 377 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakamori, T. Kimura, T. Kubota, T. Matsumura, H. Sumi, H. Fujimura, M. P. Takahashi, and S. Sakoda Aberrantly spliced {alpha}-dystrobrevin alters {alpha}-syntrophin binding in myotonic dystrophy type 1 Neurology, February 26, 2008; 70(9): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Orengo, P. Chambon, D. Metzger, D. R. Mosier, G. J. Snipes, and T. A. Cooper Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy PNAS, February 19, 2008; 105(7): 2646 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Warf and J. A. Berglund MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T RNA, December 1, 2007; 13(12): 2238 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Moroy and F. Heyd The impact of alternative splicing in vivo: Mouse models show the way RNA, August 1, 2007; 13(8): 1155 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Cooper Regulation of chloride ion conductance during skeletal muscle development and in disease. Focus on "Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1" Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1245 - C1247. [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Osborne and C. A. Thornton RNA-dominant diseases Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R162 - R169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Kanadia, J. Shin, Y. Yuan, S. G. Beattie, T. M. Wheeler, C. A. Thornton, and M. S. Swanson Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy PNAS, August 1, 2006; 103(31): 11748 - 11753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Haro, I. Al-Ramahi, B. De Gouyon, L. Ukani, A. Rosa, N. A. Faustino, T. Ashizawa, T. A. Cooper, and J. Botas MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1 Hum. Mol. Genet., July 1, 2006; 15(13): 2138 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C.M. Moraes, C. J. Wilusz, and J. Wilusz CUG-BP binds to RNA substrates and recruits PARN deadenylase RNA, June 1, 2006; 12(6): 1084 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. M. Mooers, J. S. Logue, and J. A. Berglund The structural basis of myotonic dystrophy from the crystal structure of CUG repeats PNAS, November 15, 2005; 102(46): 16626 - 16631. [Abstract] [Full Text] [PDF]
|
|